These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 36030898)
1. Arrhythmia prevalence, predictors, and impact on hospital-associated outcomes among patients with diffuse large B-cell lymphoma. Jackson I; Etuk A; Jackson N Am J Med Sci; 2023 Jan; 365(1):56-62. PubMed ID: 36030898 [TBL] [Abstract][Full Text] [Related]
2. Retrospective analyses of factors influencing arrhythmias and the impact of arrhythmias on inpatient outcomes among hospitalized patients with hemochromatosis. Jackson I; Oyenuga M; Balogun O; Oyenuga A; Etuk A; Jackson N Int J Cardiol; 2022 Apr; 352():56-60. PubMed ID: 35090986 [TBL] [Abstract][Full Text] [Related]
3. Burden of arrhythmias and predictors of mortality among multiple myeloma patients with arrhythmias. Balogun O; Jackson I; Oyenuga M; Oyenuga A; Etuk A; Jackson N J Investig Med; 2022 Aug; 70(6):1381-1386. PubMed ID: 35483747 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and Predictors of Palliative Care Utilization among Hospitalized Patients with Diffuse Large B-Cell Lymphoma. Jackson I; Etuk A; Jackson N J Palliat Care; 2023 Apr; 38(2):167-174. PubMed ID: 35006019 [No Abstract] [Full Text] [Related]
5. Trends, Sociodemographic and Hospital-Level Factors Associated With Palliative Care Utilization Among Multiple Myeloma Patients Using the National Inpatient Sample (2016-2018). Jackson I; Jackson N; Etuk A Am J Hosp Palliat Care; 2022 Aug; 39(8):888-894. PubMed ID: 34663083 [TBL] [Abstract][Full Text] [Related]
6. The Burden of Cardiac Arrhythmias in Gout: A National Representative Database Study. Mhanna M; Jabri A; Omar YA; Al-Abdouh A; Beran A; Ramahi A; Alrifai N; Almahameed S; Altorok N; Hodgson-Zingman D Curr Probl Cardiol; 2023 Jan; 48(1):101437. PubMed ID: 36183979 [TBL] [Abstract][Full Text] [Related]
7. Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma. Huntington SF; Hoag JR; Zhu W; Wang R; Zeidan AM; Giri S; Podoltsev NA; Gore SD; Ma X; Gross CP; Davidoff AJ Cancer; 2018 Nov; 124(21):4211-4220. PubMed ID: 30216436 [TBL] [Abstract][Full Text] [Related]
8. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia]. Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254 [TBL] [Abstract][Full Text] [Related]
9. Impact of Atrial Fibrillation on Inpatient Outcomes Among Hospitalized Patients With Multiple Myeloma. Jackson I; Etuk AS; Jackson N Cureus; 2022 May; 14(5):e25252. PubMed ID: 35755507 [TBL] [Abstract][Full Text] [Related]
10. National utilization and inpatient safety measures of lumbar spinal fusion methods by race/ethnicity. Reyes AM; Katz JN; Schoenfeld AJ; Kang JD; Losina E; Chang Y Spine J; 2021 May; 21(5):785-794. PubMed ID: 33227551 [TBL] [Abstract][Full Text] [Related]
11. Direct Costs Associated with Relapsed Diffuse Large B-Cell Lymphoma Therapies. Purdum A; Tieu R; Reddy SR; Broder MS Oncologist; 2019 Sep; 24(9):1229-1236. PubMed ID: 30850561 [TBL] [Abstract][Full Text] [Related]
12. Discharge dispositions, complications, and costs of hospitalization in spinal cord tumor surgery: analysis of data from the United States Nationwide Inpatient Sample, 2003-2010. Sharma M; Sonig A; Ambekar S; Nanda A J Neurosurg Spine; 2014 Feb; 20(2):125-41. PubMed ID: 24286530 [TBL] [Abstract][Full Text] [Related]
13. Clinical and Sociodemographic Predictors of Mortality in End-Stage Renal Disease Inpatients in Rural Areas of the USA: Evidence From the Nationwide Inpatient Sample. Adeyemi E; Okpe A; Enete C; Dixon K Cureus; 2022 Jun; 14(6):e25624. PubMed ID: 35784967 [TBL] [Abstract][Full Text] [Related]
14. Impact of diffuse large B-cell lymphoma on visits to different provider specialties among elderly Medicare beneficiaries: challenges for care coordination. Garg R; Sambamoorthi U; Tan X; Basu SK; Haggerty T; Kelly KM Transl Behav Med; 2018 May; 8(3):386-399. PubMed ID: 29370438 [TBL] [Abstract][Full Text] [Related]
15. Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study. Wästerlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S J Intern Med; 2019 Apr; 285(4):455-468. PubMed ID: 30368947 [TBL] [Abstract][Full Text] [Related]
16. Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.S. Yang X; Laliberté F; Germain G; Raut M; Duh MS; Sen SS; Lejeune D; Desai K; Armand P Oncologist; 2021 May; 26(5):e817-e826. PubMed ID: 33616256 [TBL] [Abstract][Full Text] [Related]
17. Association of inpatient vs outpatient onset of ST-elevation myocardial infarction with treatment and clinical outcomes. Kaul P; Federspiel JJ; Dai X; Stearns SC; Smith SC; Yeung M; Beyhaghi H; Zhou L; Stouffer GA JAMA; 2014 Nov; 312(19):1999-2007. PubMed ID: 25399275 [TBL] [Abstract][Full Text] [Related]
18. Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare Cohort. Koff JL; Rai A; Flowers CR Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e115-e121. PubMed ID: 29273217 [TBL] [Abstract][Full Text] [Related]
19. Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective. Moertl B; Dreyling M; Schmidt C; Hoster E; Schoel W; Bergwelt-Baildon MV; Berger K Clin Lymphoma Myeloma Leuk; 2022 Jul; 22(7):474-482. PubMed ID: 35033478 [TBL] [Abstract][Full Text] [Related]
20. Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study. Vijenthira A; Mozessohn L; Nagamuthu C; Liu N; Blunt D; Alibhai S; Prica A; Cheung MC J Natl Compr Canc Netw; 2022 Jun; 20(6):635-642.e9. PubMed ID: 35714676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]